{
  "id": "ic-a3b",
  "version": "1",
  "drug": {
    "slug": "sulfonylureas",
    "display": "Sulfonylureas (glimepiride, gliclazide, glibenclamide)"
  },
  "supplement": {
    "slug": "berberine",
    "display": "Berberine"
  },
  "severity": "major",
  "evidenceTier": "pharmacology-standard",
  "mechanism": "Sulfonylureas push insulin release regardless of glucose level; berberine adds a separate glucose-lowering effect. Hypoglycemia risk is higher than with metformin monotherapy.",
  "patientNotes": [
    "Do not start berberine while on a sulfonylurea unless your prescriber explicitly approves.",
    "If approved, expect closer glucose checks; treat low-sugar symptoms as urgent."
  ],
  "pmids": [
    "25498346"
  ],
  "pubmedUrls": [
    "https://pubmed.ncbi.nlm.nih.gov/25498346/"
  ],
  "guideSlugs": [
    "berberine-vs-ozempic",
    "berberine-with-semaglutide"
  ],
  "guideUrls": [
    "https://supplementbrief.com/berberine-vs-ozempic/",
    "https://supplementbrief.com/berberine-with-semaglutide/"
  ],
  "pairUrl": "https://supplementbrief.com/interactions/sulfonylureas/berberine/",
  "reviewedBy": "natallia-kalistratava",
  "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
  "lastVerified": "2026-09-05",
  "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a3b.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a3b/"
}
